Volume 29, Issue 1 And 2 (1-2025)                   IBJ 2025, 29(1 And 2): 1-8 | Back to browse issues page

Ethics code: Not applicable.


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yaghmaei H, Taromiha A, Nojoumi S A, Soltanipur M, Shahshenas S, Rezaei M, et al . Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease: A Mini Review. IBJ 2025; 29 (1 and 2) :1-8
URL: http://ibj.pasteur.ac.ir/article-1-4212-en.html
Abstract:  
Non-alcoholic fatty liver disease has emerged as a significant global health problem, mainly due to the increasing prevalence of obesity and metabolic syndrome. The gut microbiota plays an essential role in the development of NAFLD through the gut-liver axis. Dysbiosis of the GM is associated with the pathogenesis of NAFLD. Dietary choices and other lifestyle factors influence the composition of the GM and contribute to the development of NAFLD. At the phylum level, individuals with NAFLD show an increased level in Actinobacteria and Firmicutes, while Verrucomicrobia, Thermus, Proteobacteria, Lentiphaerae, and Fusobacteria are found to be decreased. Several genera, including Faecalibacterium and Akkermansia, exhibit alterations in NAFLD and are linked to disease progression. Modulating the GM through prebiotics, probiotics, or fecal microbiota transplantation represents a promising therapeutic strategy for NAFLD. This review summarizes the current understanding of GM changes in NAFLD, focusing on findings from both human and animal studies. 
Type of Study: Review Article | Subject: Molecular Microbiology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian Biomedical Journal

Designed & Developed by : Yektaweb